Carcinoembryonic antigen (CEA) serves as a popular biomarker in the diagnosis and prognosis of many cancers such as colorectal cancer (CRC) and lung cancer, and its level of >5 ng/ml was considered abnormal (19, 20). This evidence concerns the gene CEACAM5 and lung carcinoma.